Screener
Bioventus BVS EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Bioventus’s reported figures.
The source filing: Bioventus’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 7:43 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001665988-26-000042
FAQ
- What is Bioventus's EBITDA?
- Bioventus (BVS) reported EBITDA of $30.07M in Q2 2026.
- How has Bioventus's EBITDA changed year-over-year?
- Bioventus's EBITDA decreased by 1.1% year-over-year, from $30.42M to $30.07M.
- What is the long-term trend for Bioventus's EBITDA?
- Over 3 years (2022 to 2025), Bioventus's EBITDA has grown at a -3.3% compound annual growth rate (CAGR), from -$111.84M to $100.99M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Bioventus's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude